IU football team prepares for next season with ‘virtual offseason’
From burning rubber to running backyard drills, all of these are tailor-made plans.
Bloomington’s Retreat @ the Switchyard gains approval
BLOOMINGTON, Ind. (Inside INdiana Business) - The Bloomington Redevelopment Commission has approved a mixed-use development project adjacent to Switchyard Park designed to bring more affordable housing to the city.
IU reports record high summer enrollment
BLOOMINGTON, Ind. (Inside INdiana Business) - Indiana University is reporting record high enrollment for its summer semester.
IU Angel Network names first portfolio company
The IU Angel Network has announced the addition of its first portfolio company, Los Angeles-based digital marketplace Recess.
Kelley offers small business help, paid internships
BLOOMINGTON, Ind. (Inside INdiana Business) - The Indiana University Kelley School of Business says it is offering assistance to Hoosier businesses to establish an online presence for their operations.
Ivy Tech summer classes to be held online
BLOOMINGTON, Ind. (Inside INdiana Business) - Ivy Tech Community College will continue to offer classes virtually as a result of the COVID-19 pandemic.
IU creates healthcare app to track COVID
BLOOMINGTON, Ind. (Inside INdiana Business) - Indiana University has joined forces with rural healthcare providers to track patient reports of COVID-19 symptoms and help residents make informed healthcare decisions.
Indiana State University’s singing quarterback Michael Haupert
The Bluebird nightclub in Bloomington called and offered Haupert a chance to perform.
IU student creates ‘Quarantine Buddy’ program
BLOOMINGTON, Ind. (Inside INdiana Business) - A student from Indiana University has developed a virtual program to maintain social connections by remotely pairing people together based on similar interests and areas of study.
Bloomington facility tapped for COVID-19 vaccine manufacturing
New Jersey-based Catalent Inc. (NYSE: CTLT) has inked a deal with a subsidiary of Johnson & Johnson (NYSE: JNJ) for large scale manufacturing of J&J’s lead vaccine candidate for COVID-19.